To our knowledge, we are the first to report that PAR4 activation could inhibit the viability and induce the apoptosis of ESCC cells through suppressing enrichments of DNMT1 and HDAC2 at the p16 promoter via MAPK signals. The gene discussed is DNMT1; the disease is esophageal squamous cell carcinoma.